Nouscom
Pre-clinicalDevelops off-the-shelf and personalized cancer vaccines using viral vector technology.
Founded
2015
Focus
Viral Technology
About
Develops off-the-shelf and personalized cancer vaccines using viral vector technology.
Funding History
2Total raised: $102M
Series B$67MAndera PartnersJun 15, 2021
Series A$35MVersant VenturesJun 15, 2018
Company Info
TypePrivate
Founded2015
LocationBasel, Italy
StagePre-clinical
Contact
Sectors
SIMILAR COMPANIES
AAVantgarde Bio
Pre-clinical · Milan
AB ANALITICA
Pre-clinical · Padua
BetaGlue Therapeutics
Phase 1 · Milan
Adienne Pharma and Biotech
Pre-clinical · Milan
Advaxia Biologics
Pre-clinical · Milan
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile